Case Studies 11

A small company founded with the mission of developing innovative technology licensed from a leading medical center was evaluating several potential applications in the cardiovascular space. The company’s venture investors proposed an Easton Associates engagement to assist in establishing a development plan which would maximize the value of the compounds and the company. EA evaluated the potential role for the technology in each of the indications under consideration as well as potential synergies between indications, quantified the potential market size, and outlined the requirements and challenges associated with each opportunity. Equipped with a well-grounded analysis based on clinician and market feedback the company modified its development priorities to focus on high value indications.